Page last updated: 2024-08-17

quinoxalines and Cryptogenic Fibrosing Alveolitis

quinoxalines has been researched along with Cryptogenic Fibrosing Alveolitis in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Fan, G; Li, K; Liu, J; Sun, T; Tao, N1
Banjanac, M; Belamarić, D; Bosnar, M; Cedilak, M; Čužić, S; Eraković Haber, V; Faraho, I; Glojnarić, I; Ilić, K; Paravić Radičević, A1
Allard, J; Bauer, CM; Bitter, H; Budd, DC; Burns, L; Chen, L; Fine, JS; Garrido, R; Harris, P; Hogaboam, CM; Kitson, C; Liang, Z; Peng, R; Phillips, JE; Ravindran, P; Renteria, L; Sridhar, S; Stevenson, CS; Tyagi, G; Woods, J1

Other Studies

3 other study(ies) available for quinoxalines and Cryptogenic Fibrosing Alveolitis

ArticleYear
Liproxstatin-1 alleviates bleomycin-induced alveolar epithelial cells injury and mice pulmonary fibrosis via attenuating inflammation, reshaping redox equilibrium, and suppressing ROS/p53/α-SMA pathway.
    Biochemical and biophysical research communications, 2021, 04-30, Volume: 551

    Topics: A549 Cells; Actins; Alveolar Epithelial Cells; Animals; Bleomycin; Humans; Idiopathic Pulmonary Fibrosis; Inflammation; Lipid Metabolism; Male; Mice; Mice, Inbred C57BL; Oxidation-Reduction; Oxidative Stress; Quinoxalines; Reactive Oxygen Species; Spiro Compounds; Tumor Suppressor Protein p53

2021
Precision-cut lung slices from bleomycin treated animals as a model for testing potential therapies for idiopathic pulmonary fibrosis.
    Pulmonary pharmacology & therapeutics, 2019, Volume: 55

    Topics: Animals; Bleomycin; Disease Models, Animal; Idiopathic Pulmonary Fibrosis; Imidazoles; Indoles; Lung; Male; Mice; Mice, Inbred C57BL; Quinoxalines

2019
Bleomycin induces molecular changes directly relevant to idiopathic pulmonary fibrosis: a model for "active" disease.
    PloS one, 2013, Volume: 8, Issue:4

    Topics: Airway Remodeling; Animals; Antibiotics, Antineoplastic; Bleomycin; Cluster Analysis; Disease Models, Animal; Fibroblasts; Gene Expression Profiling; Gene Expression Regulation; Humans; Idiopathic Pulmonary Fibrosis; Imidazoles; Inflammation; Lung; Male; Mice; Mitosis; Protein Serine-Threonine Kinases; Quinoxalines; Receptor, Transforming Growth Factor-beta Type I; Receptors, Transforming Growth Factor beta; Signal Transduction

2013